<DOC>
	<DOCNO>NCT00617396</DOCNO>
	<brief_summary>Purpose : We propose examine , via open label trial , use Seroquel® patient moderate severe functional bowel symptom receive adequate relief symptom present regimen SNRI TCA antidepressant agent . Participants : Primary eligibility determine patient The UNC Center Functional GI &amp; Motility Disorders Clinic score moderate severe range Functional Bowel Disorders Severity Index ( FBDSI ≥ 37 ) fail incomplete treatment response medication include least one prior trial antidepressant medication . Procedures ( method ) : We monitor several patient symptom relate outcome , well evaluate health relate quality life , psychological distress relate psychosocial measure determine addition Seroquel® use antidepressant improve clinical response base adequate relief measure well select secondary outcome . We also determine treatment benefit related effect pain , associated psychological co-morbidities see population , factor .</brief_summary>
	<brief_title>Open Label Seroquel ( Quetiapine ) Study Treatment Resistant Functional Bowel Disorder</brief_title>
	<detailed_description>The UNC Center Functional GI &amp; Motility Disorders Clinic frequently receive referral patient chronic treatment refractory symptom abdominal pain bowel dysfunction . Many patient diagnose irritable bowel syndrome , painful functional constipation functional abdominal pain syndrome use Rome III criterion . The presenting symptoms referral population frequently severe range , patient intensely painful symptom , Axis I Axis II co-morbidities , impaired health relate quality life . Failure multiple standard treatment attempt prior referral customary patient see clinic . Additionally , great number patient experience partial response standard treatment . We therefore attempt address patient utilize novel treatment strategy propose .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>The subject diagnose painful functional bowel disorder lasting longer six month The subject achieve score great 37 Functional Bowel Disorders Severity Index Four week antidepressant medication lead adequate relief GI symptoms Patients , opinion investigator , pose imminent risk suicide danger self others Known intolerance lack response Seroquel judge investigator Use prohibit medicationsMedical condition would affect absorption , distribution , metabolism , excretion study treatment Unstable inadequately treat medical An absolute neutrophil count ( ANC ) ≤1.5 X 109 per liter Subject pregnant breastfeeding . Subject take medication think directly affect gut function via 5HT method action ( Tegaserod ) Known hypersensitivity duloxetine inactive ingredient duloxetine Any patient take Monoamine Oxidase Inhibitors Patient uncontrolled narrowangle glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Seroquel</keyword>
	<keyword>Abdominal Pain</keyword>
</DOC>